Drug Approval | February 24, 2024
Orchid Pharma's 'Exblifep' receives USFDA approval
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Developed by Pfizer, Abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
The orphan drug designation by the EC is issued for drugs which are intended to treat diseases that affect fewer than five in 10,000 people in the European Union
The receipt of this permission paves way for the launch of Andexanet alfa powder for solution for infusion 200 mg (Andexxa) in India
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
The Institute is catering the health needs of the surrounding population with ever-increasing OPD every year along with special OPDs like mother & Child OPD, and LSD clinic
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
Subscribe To Our Newsletter & Stay Updated
